Hypertension Clinical Trials in Chicago

Showing 141-160 of 221 trials

Study of a New Thermo Stable Formulation of Epoprostenol Sodium to Treat Pulmonary Arterial Hypertension (PAH)

NCT01462565

The purpose of this multicentre, open label, single-arm study in approximately 20 adult patients is to evaluate the Impact on lifestyle of a new thermo stable formulation of epoprostenol sodium in subjects with Pulmonary Arterial Hypertension (PAH).

Hypertension, Pulmonary

GlaxoSmithKline16 participantsStarted Nov 2011

Miami Beach, Florida, United States • Chicago, Illinois, United States • Baltimore, Maryland, United States +5 more locations

TERMINATEDPhase 32.2 miles

Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure

NCT00016523

This multicenter trial tested whether inhaled nitric oxide would reduce death or the need for oxygen in preterm infants (less than 34 weeks gestational age) with severe lung disease.

Infant, NewbornInfant, Low Birth WeightInfant, Small for Gestational Age+5 more

NICHD Neonatal Research Network420 participantsStarted Jan 2001

Birmingham, Alabama, United States • Palo Alto, California, United States • San Diego, California, United States +14 more locations

Study of a New Thermo Stable Formulation of Epoprostenol Sodium to Treat Pulmonary Arterial Hypertension (PAH)

Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure

Hypertension Trials in Other Cities

Research Study To Test Carvedilol CR + Lisinopril Versus Lisinopril + Placebo In Patients With High Blood Pressure

Using Stories to Address Disparities in Hypertension

An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II Diabetes

Improving Health Outcomes: Blood Pressure

Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)

Translating a Heart Disease Lifestyle Intervention Into the Community

An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age

Safety and Efficacy of Aliskiren in Pediatric Hypertensive Patients 6-17 Years of Age

A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma

28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension

Inhaled Nitric Oxide Study for Respiratory Failure in Newborns

AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure

Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension

DAYLIGHT: Vitamin D Therapy in Individuals at High Risk of Hypertension

Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis

Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD

Safety and Tolerability of Valsartan in Children 6 to 17 Years of Age

Other Conditions in Chicago